Polycystic_ovarian_syndrome:_safety_and_effectiveness_of_stepwise_and_low-dose_administration_of_purified_follicle-stimulating_hormone._OBJECTIVE:_An_attempt_to_induce_ovulation_with_a_single_dominant_follicle_in_polycystic_ovarian_syndrome_(PCOS)_patients._DESIGN:_Comparing_ultrasound_and_estradiol_(E2)_measurements_during_treatment_with_a_low-dose_protocol_(using_purified_follicle-stimulating_hormone,_starting_with_75_IU/d_and_increasing_every_7_days_by_37.5_IU/d)_with_those_obtained_following_treatment_with_a_conventional_protocol_using_the_same_drug._SETTING:_Specialist_Reproductive_Endocrine_Unit._PATIENTS_PARTICIPANTS:_Eight_PCOS_patients_of_whom_six_had_failed_to_respond_adequately_to_the_conventional_protocol._MAIN_OUTCOME_MEASURE:_Rate_of_cancellation_of_cycles,_number_of_leading_follicles,_and_serum_E2_concentration_at_the_time_of_ovulation._RESULTS:_Treatment_with_the_low-dose_protocol_resulted_in_a_significant_reduction_in_the_number_of_leading_follicles_(P_less_than_0.04),_serum_E2_concentrations_(P_less_than_0.0002),_and_a_higher_rate_of_ovulation._As_a_result,_five_patients_conceived_compared_with_none_in_the_conventional_protocol._CONCLUSION:_Using_the_low-dose_protocol_permitted_induction_of_ovulation_safely_and_successfully_in_a_selected_group_of_PCOS_patients_who_were_previously_difficult_to_treat_with_the_conventional_ovulation_induction_protocol.